XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Stockholders' Equity, Beginning Balance at Dec. 31, 2019 $ 37 $ 412,227 $ (104) $ (312,648) $ 99,512
Shares, Outstanding, Beginning Balance at Dec. 31, 2019 36,865,116        
Exercises of vested stock options   2,319     2,319
Exercises of vested stock options (in shares) 228,436        
Vesting of restricted stock units (in shares) 170,367        
Issuance of common stock under ESPP   1,279     1,279
Issuance of common stock under ESPP (in shares) 104,108        
Stock based compensation expense   14,499     14,499
Net unrealized loss on available-for-sale-securities     (30)   (30)
Net income (loss)       36,741 36,741
Stockholders' Equity, Ending Balance at Dec. 31, 2020 $ 37 430,324 (134) (275,907) 154,320
Shares, Outstanding, Ending Balance at Dec. 31, 2020 37,368,027        
Exercises of vested stock options $ 1 27     28
Exercises of vested stock options (in shares) 3,811        
Vesting of restricted stock units (in shares) 346,551        
Issuance of common stock under ESPP   918     918
Issuance of common stock under ESPP (in shares) 200,006        
Stock based compensation expense   10,990     10,990
Net unrealized loss on available-for-sale-securities     (4)   (4)
Net income (loss)       (71,197) (71,197)
Stockholders' Equity, Ending Balance at Dec. 31, 2021 $ 38 442,259 (138) (347,104) 95,055
Shares, Outstanding, Ending Balance at Dec. 31, 2021 37,918,395        
Exercises of vested stock options   629     $ 629
Exercises of vested stock options (in shares) 89,012       89,012
Vesting of restricted stock units (in shares) 456,219        
Issuance of common stock under ESPP   672     $ 672
Issuance of common stock under ESPP (in shares) 150,265        
Stock based compensation expense   9,153     9,153
Net unrealized loss on available-for-sale-securities     (81)   (81)
Net income (loss)       (46,408) (46,408)
Stockholders' Equity, Ending Balance at Dec. 31, 2022 $ 38 $ 452,713 $ (219) $ (393,512) $ 59,020
Shares, Outstanding, Ending Balance at Dec. 31, 2022 38,613,891